✦ LIBER ✦

CN2 ECONOMIC EVALUATION OF EGFR-GUIDEDTREATMENT IN ADVANCED REFRACTORY NON SMALL-CELL LUNG CANCER

✍ Scribed by JJ Carlson; L Garrison; S Ramsey; DL Veenstra

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

CN2 ECONOMIC EVALUATION OF NEW POLY-CHEM

✍ N Neymark; J van Meerbeeck; E Smit; P Lianes; G Giaccone 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 68 KB

Predictive value of EGFR and HER2 overex

✍ Hirsch, F R; Varella-Garcia, M; Cappuzzo, F 📂 Article 📅 2009 🏛 Nature Publishing Group 🌐 English ⚖ 201 KB

CN3: AN ECONOMIC MODEL FOR THE PHARMACOL

✍ SV Sorensen; M Chambers; A Heyes 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 51 KB

Double mutation and gene copy number of

✍ Tokumo, Masaki; Toyooka, Shinichi; Ichihara, Shuji; Ohashi, Kadoaki; Tsukuda, Ka 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 435 KB

Association of epidermal growth factor r

✍ Ryotaro Morinaga; Isamu Okamoto; Yoshihiko Fujita; Tokuzo Arao; Masaru Sekijima; 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 195 KB

EGFR inhibition in the treatment of non-

✍ David E. Gerber 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 154 KB 👁 2 views